Baxter S.A. sought to streamline its operations, manage operating costs, and conform to the U.S. Food and Drug Administration’s compliance standards. To achieve these goals, Baxter needed to revise its manufacturing facility processes to incorporate automation methods into a new production line. Baxter partnered with BiiON, which specializes in pharmaceutical and biotechnology industry system integration, to ensure the successful implementation of the new manufacturing line. With its new system in place, Baxter’s facility simplified monitoring and reporting, ensured regulatory compliance, and doubled production.
“To be successful, strategic projects require excellent collaboration between the customer, the software vendor, and the integrator. By establishing the automation framework, AVEVA software enabled our project teams to focus on productivity targets.”
Serge Bassem, CEO, BiiON
Goals
- Increasing production capacity while reducing manufacturing throughput time
- Incorporating automation in a new production line to comply with U.S. FDA regulations
Challenge
- Keeping automation system compatible with existing architecture and systems
- Centralizing production management to include reporting, analysis and traceability
- Ensuring performance monitoring complies with US and European standards
Solutions
- AVEVA™ InTouch HMI
- AVEVA™ System Platform
- AVEVA™ Batch Management
- AVEVA™ Historian
Results
- Doubled productivity at the manufacturing facility
- Manufacturing processes are fully traceable and comply with US and European regulations
- New generic objects library simplifies batch management
